Asunto(s)
Antivirales/uso terapéutico , Cloroquina/uso terapéutico , Infecciones por Coronavirus/tratamiento farmacológico , Neumonía Viral/tratamiento farmacológico , Betacoronavirus , COVID-19 , Cloroquina/efectos adversos , Cloroquina/provisión & distribución , Humanos , Pandemias , SARS-CoV-2 , Insuficiencia del TratamientoRESUMEN
Isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) are key metabolic enzymes that convert isocitrate to alpha-ketoglutarate (alphaKG). Somatic point mutations in IDH1/2 that are found in rare distinct subsets of cancers confer a gain of function in cancer cells which results in the accumulation and secretion in vast excess of the oncometabolite D-2-hydroxyglutarate (D-2HG). Overproduction of D-2HG interferes with cellular metabolism and epigenetic regulation, contributing to oncogenesis. High levels of D-2HG inhibit alphaKG-dependent dioxygenases including histone, DNA and RNA demethylases, resulting in histone, DNA and RNA hypermethylation and cell differentiation blockade. In addition, D-2HG is a biomarker suitable for the detection of IDH1/2 mutations at diagnosis, and is also predictive of clinical response. The U.S. Food and Drug Administration (FDA) approved ivosidenib, a mutant-IDH1 enzyme inhibitor, for patients with relapsed or refractory IDH1-mutated acute myeloid leukemia (AML) in 2018, and also as front-line therapy for newly diagnosed elderly patients 75 years or older or who are ineligible to receive intensive chemotherapy in 2019. Ivosidenib represents a novel drug class for targeted therapy in AML.
Asunto(s)
Glicina/análogos & derivados , Isocitrato Deshidrogenasa/genética , Leucemia Mieloide Aguda/tratamiento farmacológico , Piridinas/uso terapéutico , Adulto , Anciano , Antineoplásicos/uso terapéutico , Inhibidores Enzimáticos/uso terapéutico , Epigénesis Genética , Glicina/uso terapéutico , Humanos , MutaciónRESUMEN
OBJECTIVES: To identify factors associated with unfavourable in-hospital outcome (death or disability) in adults with community-acquired bacterial meningitis (CABM). METHODS: In a prospective multicentre cohort study (COMBAT; February 2013 to July 2015), all consecutive cases of CABM in the 69 participating centres in France were enrolled and followed up for 12 months. Factors associated with unfavourable outcome were identified by logistic regression and long-term disability was analysed. RESULTS: Among the 533 individuals enrolled, (Streptococcus pneumoniae 53.8% (280/520 isolates identified), Neisseria meningitidis 21.3% (111/520), others 24.9% (129/520)), case fatality rate was 16.9% (90/533) and unfavourable outcome occurred in 45.0% (225/500). Factors independently associated with unfavourable outcome were: age >70 years (adjusted odds ratio (aOR) 4.64; 95% CI 1.93-11.15), male gender (aOR 2.11; 95% CI 1.25-3.57), chronic renal failure (aOR 6.65; 95% CI 1.57-28.12), purpura fulminans (aOR 4.37; 95% CI 1.38-13.81), localized neurological signs (aOR 3.72; 95% CI 2.29-6.05), disseminated intravascular coagulation (aOR 3.19; 95% CI 1.16-8.79), cerebrospinal fluid (CSF) white-cell count <1500 cells/µL (aOR 2.40; 95% CI 1.42-4.03), CSF glucose concentration (0.1-2.5 g/L: aOR 1.92; 95% CI 1.01-3.67; <0.1 g/L: aOR 2.24; 95% CI 1.01-4.97), elevated CSF protein concentration (aOR 1.09; 95% CI 1.03-1.17), time interval between hospitalization and lumbar puncture >1 day (aOR 2.94; 95% CI 1.32-6.54), and S. pneumoniae meningitis (aOR 4.99; 95% CI 1.98-12.56), or meningitis other than N. meningitidis (aOR 4.54; 95% CI 1.68-12.27). At 12 months, 26.7% (74/277) had hearing loss, 32.8% (87/265) depressive symptoms, 31.0% (86/277) persistent headache, and 53.4% had a physical health-related quality of life (142/266) <25th centile of the distribution of the score in the general French population (p < 0.0001). CONCLUSIONS: The burden of CABM (death, disability, depression, impaired quality of life and hearing loss) is high. Identification of cases from the first symptoms may improve prognosis. CLINICALTRIAL: Gov identification number: NCT01730690.
Asunto(s)
Infecciones Comunitarias Adquiridas/microbiología , Infecciones Comunitarias Adquiridas/patología , Meningitis Bacterianas/complicaciones , Meningitis Bacterianas/patología , Adulto , Anciano , Antibacterianos/administración & dosificación , Antibacterianos/uso terapéutico , Estudios de Cohortes , Infecciones Comunitarias Adquiridas/tratamiento farmacológico , Infecciones Comunitarias Adquiridas/mortalidad , Femenino , Hospitalización , Humanos , Masculino , Meningitis Bacterianas/tratamiento farmacológico , Meningitis Bacterianas/mortalidad , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Estudios Prospectivos , Factores de Riesgo , Resultado del TratamientoAsunto(s)
Infecciones por Alphavirus , Alphavirus , Fiebre Chikungunya , Alphavirus/clasificación , Alphavirus/genética , Alphavirus/aislamiento & purificación , Infecciones por Alphavirus/diagnóstico , Infecciones por Alphavirus/epidemiología , Infecciones por Alphavirus/inmunología , Infecciones por Alphavirus/prevención & control , Américas/epidemiología , Animales , Región del Caribe/epidemiología , Fiebre Chikungunya/diagnóstico , Fiebre Chikungunya/epidemiología , Fiebre Chikungunya/inmunología , Fiebre Chikungunya/prevención & control , Virus Chikungunya/genética , Virus Chikungunya/aislamiento & purificación , Brotes de Enfermedades , Reservorios de Enfermedades/virología , Genoma Viral , Humanos , Mosquitos Vectores/virología , Virus O'nyong-nyong/genética , Virus O'nyong-nyong/aislamiento & purificación , Patología Molecular , Filogenia , Primates/virología , Estudios Seroepidemiológicos , Pruebas Serológicas , Zoonosis/virologíaRESUMEN
The GloPID-R (Global Research Collaboration for Infectious Disease Preparedness) Chikungunya (CHIKV), O'nyong-nyong (ONNV) and Mayaro virus (MAYV) Working Group is investigating the natural history, epidemiology and medical management of infection by these viruses, to identify knowledge gaps and to propose recommendations for direct future investigations and rectification measures. Here, we present the first report dedicated to diagnostic aspects of CHIKV, ONNV and MAYV. Regarding diagnosis of the disease at the acute phase, molecular assays previously described for the three viruses require further evaluation, standardized protocols and the availability of international standards representing the genetic diversity of the viruses. Detection of specific IgM would benefit from further investigations to clarify the extent of cross-reactivity among the three viruses, the sensitivity of the assays, and the possible interfering role of cryoglobulinaemia. Implementation of reference panels and external quality assessments for both molecular and serological assays is necessary. Regarding sero-epidemiological studies, there is no reported high-throughput assay that can distinguish among these different viruses in areas of potential co-circulation. New specific tools and/or improved standardized protocols are needed to enable large-scale epidemiological studies of public health relevance to be performed. Considering the high risk of future CHIKV, MAYV and ONNV outbreaks, the Working Group recommends that a major investigation should be initiated to fill the existing diagnostic gaps.
Asunto(s)
Infecciones por Alphavirus/diagnóstico , Fiebre Chikungunya/diagnóstico , Enfermedades Transmisibles Emergentes/diagnóstico , Alphavirus/genética , Alphavirus/inmunología , Alphavirus/aislamiento & purificación , Infecciones por Alphavirus/epidemiología , Animales , Anticuerpos Antivirales , Virus Chikungunya/genética , Virus Chikungunya/inmunología , Virus Chikungunya/aislamiento & purificación , Enfermedades Transmisibles Emergentes/epidemiología , Reacciones Cruzadas , Crioglobulinemia/virología , Genes Virales , Humanos , Mosquitos Vectores/virología , Virus O'nyong-nyong/genética , Virus O'nyong-nyong/inmunología , Virus O'nyong-nyong/aislamiento & purificación , Patología Molecular , Filogenia , Estudios SeroepidemiológicosRESUMEN
OBJECTIVES: Listeria monocytogenes (Lm) is a foodborne human pathogen responsible for severe infections, including septicaemia, neurolisteriosis, and maternal-foetal and focal infections. Little is known about Lm-associated respiratory tract or lung infections. METHODS: We conducted a retrospective study of culture-proven cases of Lm pleural infections and pneumonia reported to the French National Reference Centre for Listeria from January 1993 to August 2016. RESULTS: Thirty-eight consecutive patients with pleural infection (n = 32), pneumonia (n = 5), or both (n = 1) were studied; 71% of these were men. Median age was 72 (range 29-90). Two patients presented with concomitant neurolisteriosis. All patients but one reported at least one immunosuppressive condition (97%), with a median number of 2 (range 0-5), including 29% (8/28) with current exposure to immunosuppressive therapy and 50% (17/34) with ongoing neoplasia; 75% (21/28) reported previous pleural or pulmonary disease. Antibiotic therapy mostly consisted in amoxicillin (72%) associated with aminoglycoside in 32%. Chest-tube drainage was performed in 7/19 patients with empyema (37%); 25% of the patients (7/30) required intensive care management. In-hospital mortality reached 35% and occurred after a median time interval of 4 days (range 1-33 days). Three patients had recurrence of empyema (time interval of 1 week to 4 months after treatment completion). Altogether, only 13/31 patients (42%) diagnosed with Lm respiratory infection experienced an uneventful outcome at 2-year follow-up. CONCLUSION: Lm is a rare but severe cause of pneumonia and pleural infection in older immunocompromised patients, requiring prompt diagnosis and adequate management and follow-up.
Asunto(s)
Listeriosis/complicaciones , Listeriosis/epidemiología , Enfermedades Pulmonares/epidemiología , Enfermedades Pulmonares/microbiología , Infecciones del Sistema Respiratorio/epidemiología , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/uso terapéutico , Empiema Pleural/tratamiento farmacológico , Empiema Pleural/epidemiología , Empiema Pleural/etiología , Empiema Pleural/microbiología , Femenino , Humanos , Listeria monocytogenes/efectos de los fármacos , Listeria monocytogenes/aislamiento & purificación , Listeriosis/tratamiento farmacológico , Listeriosis/microbiología , Enfermedades Pulmonares/tratamiento farmacológico , Enfermedades Pulmonares/etiología , Masculino , Persona de Mediana Edad , Pleuroneumonía/tratamiento farmacológico , Pleuroneumonía/epidemiología , Pleuroneumonía/etiología , Pleuroneumonía/microbiología , Neumonía Bacteriana/tratamiento farmacológico , Neumonía Bacteriana/epidemiología , Neumonía Bacteriana/etiología , Neumonía Bacteriana/microbiología , Infecciones del Sistema Respiratorio/tratamiento farmacológico , Infecciones del Sistema Respiratorio/etiología , Infecciones del Sistema Respiratorio/microbiología , Estudios Retrospectivos , Sepsis/tratamiento farmacológico , Sepsis/epidemiología , Sepsis/etiología , Sepsis/microbiologíaAsunto(s)
Encefalitis Infecciosa/tratamiento farmacológico , Adulto , Antiinfecciosos/uso terapéutico , Anticonvulsivantes/uso terapéutico , Quimioterapia Combinada , Humanos , Hipnóticos y Sedantes/uso terapéutico , Encefalitis Infecciosa/sangre , Encefalitis Infecciosa/líquido cefalorraquídeo , Encefalitis Infecciosa/diagnóstico , Neuroimagen , Fármacos Neuroprotectores/uso terapéutico , Convulsiones/tratamiento farmacológico , Convulsiones/etiología , Punción EspinalRESUMEN
INTRODUCTION: The etiological diagnosis of infectious encephalitis is often not established 48hours after onset. We aimed to review existing literature data before providing management guidelines. METHOD: We performed a literature search on PubMed using filters such as "since 01/01/2000", "human", "adults", "English or French", and "clinical trial/review/guidelines". We also used the Mesh search terms "encephalitis/therapy" and "encephalitis/diagnosis". RESULTS: With Mesh search terms "encephalitis/therapy" and "encephalitis/diagnosis", we retrieved 223 and 258 articles, respectively. With search terms "encephalitis and corticosteroid", we identified 38 articles, and with "encephalitis and doxycycline" without the above-mentioned filters we identified 85 articles. A total of 210 articles were included in the analysis. DISCUSSION: Etiological investigations must focus on recent travels, animal exposures, age, immunodeficiency, neurological damage characteristics, and potential extra-neurological signs. The interest of a diagnosis of encephalitis for which there is no specific treatment is also to discontinue any empirical treatments initially prescribed. Physicians must consider and search for autoimmune encephalitis.
Asunto(s)
Encefalitis Infecciosa/terapia , Adulto , Antiinfecciosos/uso terapéutico , Enfermedades Autoinmunes del Sistema Nervioso/diagnóstico , Diagnóstico Diferencial , Manejo de la Enfermedad , Humanos , Encefalitis Infecciosa/líquido cefalorraquídeo , Encefalitis Infecciosa/diagnóstico , Factores de TiempoRESUMEN
OBJECTIVE: Infections are the major cause of morbidity and mortality in immunocompromised patients. Improving microbiological diagnosis in these patients is of paramount clinical importance. METHODS: We performed this multicentre, blinded, prospective, proof-of-concept study, to compare untargeted next-generation sequencing with conventional microbiological methods for first-line diagnosis of infection in 101 immunocompromised adults. Patients were followed for 30 days and their blood samples, and in some cases nasopharyngeal swabs and/or biological fluids, were analysed. At the end of the study, expert clinicians evaluated the results of both methods. The primary outcome measure was the detection rate of clinically relevant viruses and bacteria at inclusion. RESULTS: Clinically relevant viruses and bacteria identified by untargeted next-generation sequencing and conventional methods were concordant for 72 of 101 patients in samples taken at inclusion (κ test=0.2, 95% CI 0.03-0.48). However, clinically relevant viruses and bacteria were detected in a significantly higher proportion of patients with untargeted next-generation sequencing than conventional methods at inclusion (36/101 (36%) vs. 11/101 (11%), respectively, p <0.001), and even when the latter were continued over 30 days (19/101 (19%), p 0.003). Untargeted next-generation sequencing had a high negative predictive value compared with conventional methods (64/65, 95% CI 0.95-1). CONCLUSIONS: Untargeted next-generation sequencing has a high negative predictive value and detects more clinically relevant viruses and bacteria than conventional microbiological methods. Untargeted next-generation sequencing is therefore a promising method for microbiological diagnosis in immunocompromised adults.
Asunto(s)
Enfermedades Transmisibles/diagnóstico , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Huésped Inmunocomprometido , Técnicas de Diagnóstico Molecular/métodos , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Técnicas Microbiológicas , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Prueba de Estudio Conceptual , Estudios ProspectivosAsunto(s)
Bacteriuria/microbiología , Listeria monocytogenes/aislamiento & purificación , Listeriosis/epidemiología , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Francia/epidemiología , Humanos , Huésped Inmunocomprometido , Listeria monocytogenes/genética , Listeriosis/diagnóstico , Listeriosis/microbiología , Listeriosis/orina , Masculino , Persona de Mediana EdadRESUMEN
A boy with X-linked agammaglobulinemia experienced progressive global motor decline, cerebellar syndrome, and epilepsy. All standard polymerase chain reactions for neurotropic viruses were negative on cerebrospinal fluid and brain biopsy. Next-generation sequencing allowed fast identification of a new astrovirus strain (HAstV-VA1/HMO-C-PA), which led to tailor the patient's treatment, with encouraging clinical monitoring over 1 year.
Asunto(s)
Agammaglobulinemia/complicaciones , Infecciones por Astroviridae/tratamiento farmacológico , Infecciones por Astroviridae/virología , Astroviridae/genética , Encefalitis Viral/tratamiento farmacológico , Encefalitis Viral/virología , Enfermedades Genéticas Ligadas al Cromosoma X/complicaciones , Adolescente , Agammaglobulinemia/tratamiento farmacológico , Antiinflamatorios/uso terapéutico , Antivirales/administración & dosificación , Antivirales/uso terapéutico , Astroviridae/clasificación , Astroviridae/aislamiento & purificación , Infecciones por Astroviridae/diagnóstico , Enfermedades Cerebelosas/tratamiento farmacológico , Enfermedades Cerebelosas/etiología , Encefalitis Viral/diagnóstico , Epilepsia/tratamiento farmacológico , Epilepsia/etiología , Enfermedades Genéticas Ligadas al Cromosoma X/tratamiento farmacológico , Genoma Viral , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Masculino , Análisis de Secuencia de ARNRESUMEN
Non-Hodgkin lymphomas (NHLs) are malignant proliferations of lymphoid cells. Lymphoid cells proliferate in a physiological manner in response to antigen-dependent and antigen-independent signals. Some lymphotropic viruses, such as Epstein-Barr virus and human T-lymphotropic virus 1, as well as pathogens leading to chronic antigenic stimulation (such as Helicobacter pylori and hepatitis C virus), are associated with NHL. We review here some of the pathophysiological features of infection-associated NHL.
Asunto(s)
Enfermedades Transmisibles/complicaciones , Linfoma no Hodgkin/epidemiología , Linfoma no Hodgkin/patología , Helicobacter pylori/inmunología , Helicobacter pylori/fisiología , Hepacivirus/inmunología , Hepacivirus/fisiología , Herpesvirus Humano 4/inmunología , Herpesvirus Humano 4/fisiología , Virus Linfotrópico T Tipo 1 Humano/inmunología , Virus Linfotrópico T Tipo 1 Humano/fisiología , Humanos , Linfoma no Hodgkin/microbiología , Linfoma no Hodgkin/virologíaRESUMEN
This study describes trends in the incidence of pregnancy-related listeriosis in France between 1984 and 2011, and presents the major characteristics of 606 cases reported between 1999 and 2011 to the French Institute for Public Health Surveillance through the mandatory notification system. The incidence of pregnancy-related listeriosis decreased by a factor of 12 from 1984 to 2011. This reduction was a result of progressive implementation of specific Listeria monocytogenes control measures in food production. A lower incidence of pregnancy-related listeriosis was observed in regions with a lower prevalence of toxoplasmosis. Given that dietary recommendations in pregnancy target both toxoplasmosis and listeriosis prevention, we suppose that recommendations may have been delivered and followed more frequently in these regions. Cases reported between 1999 and 2011 (n=606) were classified as maternal infections with ongoing pregnancy (n=89, 15%), fetal loss (n=166, 27%), or live-born neonatal listeriosis (n=351, 58%). The majority of live-born neonatal listeriosis cases (n=216, 64%) were preterm births (2236 weeks of gestation), of whom 14% (n=30) were extremely preterm births (2227 weeks of gestation). Eighty per cent of mothers reported having eaten high risk food during pregnancy. A better awareness of dietary recommendations in pregnant women is therefore necessary.
Asunto(s)
Notificación de Enfermedades/estadística & datos numéricos , Brotes de Enfermedades/estadística & datos numéricos , Enfermedades del Recién Nacido/epidemiología , Listeria monocytogenes/aislamiento & purificación , Listeriosis/epidemiología , Complicaciones Infecciosas del Embarazo/epidemiología , Adulto , Femenino , Enfermedades Transmitidas por los Alimentos/epidemiología , Enfermedades Transmitidas por los Alimentos/microbiología , Francia/epidemiología , Humanos , Incidencia , Recién Nacido , Enfermedades del Recién Nacido/microbiología , Listeriosis/microbiología , Notificación Obligatoria , Embarazo , Complicaciones Infecciosas del Embarazo/microbiología , Vigilancia en Salud Pública , Encuestas y CuestionariosRESUMEN
Granulomas may develop as a response to a local antigenic trigger, leading to the activation of macrophages and T-lymphocytes. Primary immunodeficiency (PID) is associated with the development of extensive cutaneous granulomas, whose aetiology remains unknown. We performed high-throughput sequencing of the transcriptome of cutaneous granuloma lesions on two consecutive index cases, and RT-PCR in a third consecutive patient. The RA27/3 vaccine strain of rubella virus-the core component of a universally used paediatric vaccine-was present in the cutaneous granuloma of these three consecutive PID patients. Controls included the healthy skin of two patients, non-granulomatous cutaneous lesions of patients with immunodeficiency, and skin biopsy samples of healthy individuals, and were negative. Expression of viral antigens was confirmed by immunofluorescence. Persistence of the rubella vaccine virus was also demonstrated in granuloma lesions sampled 4-5 years earlier. The persistence of the rubella virus vaccine strain in all three consecutive cutaneous granuloma patients with PID strongly suggests a causal relationship between rubella virus and granuloma in this setting.
Asunto(s)
Granuloma/virología , Síndromes de Inmunodeficiencia/virología , Vacuna contra la Rubéola/inmunología , Virus de la Rubéola/genética , Piel/patología , Adolescente , Antígenos Virales/metabolismo , Niño , Preescolar , Femenino , Perfilación de la Expresión Génica , Granuloma/genética , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Síndromes de Inmunodeficiencia/genética , Masculino , Vacuna contra la Rubéola/genética , Virus de la Rubéola/inmunología , Virus de la Rubéola/aislamiento & purificación , Análisis de Secuencia de ARNRESUMEN
Campylobacter has been associated with immunoproliferative small intestinal disease (IPSID), on the basis of 16S rDNA sequencing, in situ hybridization, and immunohistochemistry. Here, for the first time, we have cultured Campylobacter from the stools of a patient with IPSID. Phenotypic analysis and whole genome sequencing identified Campylobacter coli. PCR on a IPSID tissue biopsy sample was positive for Campylobacter coli and negative for Campylobacter jejuni. These findings further support a causative role for Campylobacter in the development of IPSID.
Asunto(s)
Campylobacter coli/aislamiento & purificación , Heces/microbiología , Enfermedad Inmunoproliferativa del Intestino Delgado/microbiología , Análisis de Secuencia de ADN , Adulto , Campylobacter coli/genética , ADN Bacteriano/química , ADN Bacteriano/genética , Genoma Bacteriano , Histocitoquímica , Humanos , Inmunohistoquímica , Enfermedad Inmunoproliferativa del Intestino Delgado/patología , Masculino , Microscopía , Tomografía de Emisión de Positrones , Radiografía AbdominalRESUMEN
OBJECTIVES: We aimed at evaluating the prevalence of Listeria species isolated from food samples and characterizing food and human cases isolates. MATERIAL AND METHODS: Between 2005 and 2007, one hundred food samples collected in the markets of Tunis were analysed in our study. Five strains of Listeria monocytogenes responsible for human listeriosis isolated in hospital of Tunis were included. Multiplex PCR serogrouping and pulsed field gel electrophoresis (PFGE) applying the enzyme AscI and ApaI were used for the characterization of isolates of L. monocytogenes. We have developed a rapid microarray-based assay to a reliable discrimination of species within the Listeria genus. RESULTS: The prevalence of Listeria spp. in food samples was estimated at 14% by using classical biochemical identification. Two samples were assigned to L. monocytogenes and 12 to L. innocua. DNA microarray allowed unambiguous identification of Listeria species. Our results obtained by microarray-based assay were in accordance with the biochemical identification. The two food L. monocytogenes isolates were assigned to the PCR serogroup IIa (serovar 1/2a). Whereas human L. monocytogenes isolates were of PCR serogroup IVb, (serovars 4b). These isolates present a high similarity in PFGE. Food L. monocytogenes isolates were classified into two different pulsotypes. These pulsotypes were different from that of the five strains responsible for the human cases. CONCLUSION: We confirmed the presence of Listeria spp. in variety of food samples in Tunis. Increased food and clinical surveillance must be taken into consideration in Tunisia to identify putative infections sources.
Asunto(s)
Técnicas de Tipificación Bacteriana/métodos , Microbiología de Alimentos , Listeria/aislamiento & purificación , Listeriosis/microbiología , Análisis de Secuencia por Matrices de Oligonucleótidos , Anciano de 80 o más Años , Animales , Proteínas Bacterianas/genética , Líquido Cefalorraquídeo/microbiología , Infección Hospitalaria/epidemiología , Infección Hospitalaria/microbiología , ADN Bacteriano/análisis , Brotes de Enfermedades , Electroforesis en Gel de Campo Pulsado , Femenino , Peces/microbiología , Abastecimiento de Alimentos/normas , Genes Bacterianos , Humanos , Lactante , Recién Nacido , Lipoproteínas/genética , Listeria/clasificación , Listeria/genética , Listeriosis/epidemiología , Masculino , Carne/microbiología , Embarazo , Prevalencia , Serotipificación , Túnez/epidemiología , Salud Urbana , Virulencia/genéticaRESUMEN
Listeria monocytogenes infection during pregnancy can lead to dramatic fetal or neonatal outcomes. No clinical trial has evaluated treatment options, and retrospective studies of cases are therefore important to define optimal regimens. We report four cases of materno-neonatal listeriosis illustrating inadequate antimicrobial therapy management and discuss recommended treatment options.
Asunto(s)
Listeria monocytogenes , Listeriosis/tratamiento farmacológico , Listeriosis/microbiología , Complicaciones Infecciosas del Embarazo/tratamiento farmacológico , Complicaciones Infecciosas del Embarazo/microbiología , Adulto , Manejo de la Enfermedad , Femenino , Humanos , Recién Nacido , Listeriosis/diagnóstico , Embarazo , Complicaciones Infecciosas del Embarazo/diagnóstico , Resultado del Tratamiento , Adulto JovenRESUMEN
Nocardiosis is a rare opportunistic infection caused by Nocardia spp., an aerobic actinomycete, that mainly affects patients with cell-mediated immunity defects, such as transplant recipients. Despite recent progress regarding Nocardia identification and changes in taxonomic assignment, many challenges remain for the diagnosis or management of nocardiosis. This opportunistic infection affects 0.04 to 3.5 % of patients with solid organ or hematopoietic stem cell transplantation, depending on the organ transplanted, cytomegalovirus (CMV) infection, corticosteroids dose and calcineurin inhibitors level. Nocardiosis diagnosis relies on appropriate clinical, radiological and microbiological workup that includes the sampling of an accessible involved site and molecular microbiology tools. In parallel, extensive clinical and radiological evaluations are mandatory, including brain imaging, even in the absence of neurological signs. In transplanted patients, differential diagnosis is challenging, with co-infections reported in 20 to 64 % of cases. As the antibiotic susceptibility pattern varies among species, the antimicrobial regimen before species identification should rely on the association of antibiotics active on all species of Nocardia. Bactericidal antibiotics are required in cases of severe or disseminated disease. Furthermore, in transplant recipients, combination therapy is difficult to manage because of cumulative toxicity and interactions with immunosuppressive agents. Because of a high recurrence rate, antibiotic therapy should be prescribed for 6 to 12 months.
Asunto(s)
Nocardiosis/epidemiología , Nocardia/aislamiento & purificación , Receptores de Trasplantes , Trasplante/efectos adversos , Antibacterianos/uso terapéutico , Humanos , Huésped Inmunocomprometido , Nocardiosis/diagnóstico , Nocardiosis/tratamiento farmacológicoRESUMEN
Listeria monocytogenes was isolated in two neonates born consecutively in the same hospital in France. The isolates had indistinguishable pulsed-field electrophoresis profiles. Retrospective epidemiological investigations found no evidence of a food-borne or environmental source. Infection control protocols and decontamination processes were in accordance with standard recommendations. The timing of onset of these infections within the same maternity unit, and the similarity of pulsed-field gel electrophoresis profiles suggests cross-infection of L. monocytogenes between the two neonates.